Margins Matter.

‘Get it all’ in your first lumpectomy with MarginProbe.

Doctors answer patients' questions about MarginProbe

 
 
 

MarginProbe helps surgeons assess margins in the operating room.

For breast surgeons, there are critical questions with every lumpectomy performed: Did I remove the right amount of tissue? Are the margins clean? Will I be able to tell my patient that we’ve removed all of the cancer? Did I do my job well?
The MarginProbe® System is a new technology to provide surgeons, for the first time, with the ability to perform an intraoperative margin assessment — a diagnostic procedure to better identify whether the tissue excised during the lumpectomy has positive margins. In approximately five minutes, within the operating room, surgeons can now have immediate information about the presence of cancer cells on the margins of the tumor.
Breast surgeons have said that this is the first significant advance in margin assessment in thirty years.
On December 28, 2012, the MarginProbe System received Premarket Approval by the US Food and Drug Administration.
Margin Probe_OR_10604_b

Latest MarginProbe news

Dr Vincent Reid is the Chairman of Surgery and Head of Surgical Oncology Services at Mercy Medical Center in Cedar Rapids Iowa. He also serves as Assistant Professor of Surgery… Read more
MarginProbe recognized as a noteworthy medical device for helping reduce positive margins for lumpectomy surgeries by Tim Clay during an interview for News Medical Life Sciences. Dune Medical develops, manufactures,… Read more
PRESS RELEASE (November 16, 2016 – Paoli, PA and New York) Dune Medical Devices today announced that CEO Lori Chmura is scheduled to present at the Canaccord Genuity Medical Technologies… Read more

Find a surgeon that uses MarginProbe!